Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 References

SKF-77,434

●Português ●Српски / srpski ●Srpskohrvatski / српскохрватски ●Türkçe Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version Appearance From Wikipedia, the free encyclopedia (Redirected from SKF-77434)

SKF-77,434

Identifiers

IUPAC name

3-allyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol

CAS Number

104422-04-0

PubChem CID

1241

ChemSpider

1204^Y

UNII

XA99M7XZR5

ChEBI

CHEBI:63988

ChEMBL

ChEMBL288090

CompTox Dashboard (EPA)

DTXSID3043817

Chemical and physical data

Formula

C₁₉H₂₁NO₂

Molar mass

295.382 g·mol⁻¹

3D model (JSmol)

Interactive image

SMILES

c3ccccc3C2CN(CC=C)CCc(cc1O)c2cc1O

InChI

InChI=1S/C19H21NO2/c1-2-9-20-10-8-15-11-18(21)19(22)12-16(15)17(13-20)14-6-4-3-5-7-14/h2-7,11-12,17,21-22H,1,8-10,13H2

Key:QBUVZVXIRYFENV-UHFFFAOYSA-N

(verify)

SKF-77,434 is a drug which acts as a selective dopamine D₁ receptor partial agonist, and has stimulant and anorectic effects. Unlike other D₁ agonists with higher efficacy such as SKF-81,297 and 6-Br-APB, SKF-77,434 does not maintain self-administration in animal studies, and so has been researched as a potential treatment for cocaine addiction.^[1]^[2]^[3]^[4]^[5]^[6]^[7]

References[edit]

^ Grech DM, Spealman RD, Bergman J (May 1996). "Self-administration of D1 receptor agonists by squirrel monkeys". Psychopharmacology. 125 (2): 97–104. doi:10.1007/BF02249407. PMID 8783382. S2CID 36378721.

^ Weed MR, Paul IA, Dwoskin LP, Moore SE, Woolverton WL (October 1997). "The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys". The Journal of Pharmacology and Experimental Therapeutics. 283 (1): 29–38. PMID 9336305.

^ Platt DM, Rowlett JK, Spealman RD (June 2000). "Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434". The Journal of Pharmacology and Experimental Therapeutics. 293 (3): 1017–26. PMID 10869406.

^ Platt DM, Rowlett JK, Spealman RD (September 2001). "Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys". Psychopharmacology. 157 (2): 208–16. doi:10.1007/s002130100779. PMID 11594448. S2CID 6567384.

^ Mutschler NH, Bergman J (April 2002). "Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys". Psychopharmacology. 160 (4): 362–70. doi:10.1007/s00213-001-0976-z. PMID 11919663. S2CID 20483120.

^ Desai RI, Terry P, Katz JL (August 2005). "A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice". Pharmacology, Biochemistry, and Behavior. 81 (4): 843–8. doi:10.1016/j.pbb.2005.06.006. PMID 16000217. S2CID 2525256.

^ Katz JL, Kopajtic TA, Terry P (June 2006). "Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats". Behavioural Pharmacology. 17 (4): 303–9. doi:10.1097/01.fbp.0000205015.67079.f7. PMID 16914948. S2CID 24288989.